Integrated Wealth Concepts’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Integrated Wealth Concepts’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73.3K	Buy	+2,170	New	+$65.1K	﹤0.01%	3060
2024 Q3	–	Sell	-8,887	Closed	-$205K	–	1709
2024 Q2	$205K	Sell	8,887 -509	-5%	-$11.9K	﹤0.01%	1513
2024 Q1	$226K	Sell	9,396 -9,246	-50%	-$217K	﹤0.01%	1467
2023 Q4	$429K	Sell	18,642 -38,237	-67%	-$768K	0.01%	1068
2023 Q3	$1.16M	Sell	56,879 -9,770	-15%	-$219K	0.02%	633
2023 Q2	$1.56M	Buy	66,649 +55,773	+513%	+$1.34M	0.03%	541
2023 Q1	$253K	Buy	+10,876	New	+$272K	0.01%	1137

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integrated Wealth Concepts's IDNA Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026: 2,170 shares worth $73.3K. The stake represents ﹤0.01% of the portfolio and ranks #3060 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in IDNA as recently as Q2 2024.

Integrated Wealth Concepts first reported a position in IDNA in Q1 2023 and has held it in 7 quarters since. The position peaked at $1.56M in Q2 2023. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Integrated Wealth Concepts held 2,170 shares of iShares Genomics Immunology and Healthcare ETF worth $73.3K as of Q2 2026.
iShares Genomics Immunology and Healthcare ETF was a new Integrated Wealth Concepts position in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3060 holding.
Integrated Wealth Concepts first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and has held it in 7 quarters since.
Integrated Wealth Concepts's iShares Genomics Immunology and Healthcare ETF position peaked at $1.56M in Q2 2023.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.